[Intestinal trematodiases (metagonimiasis, nanophyetiasis): clinico-parasitological research and the first trial of using Azinox in a focus of the lower Amur River valley].

Abstract	A focus of metagonimiasis and nanophyetiasis is described with the average human prevalence of 66.7 and 4.2%, respectively and low intensity of invasions (less than 100 eggs per 1 g). Metagonimiasis and nanophyetiasis are clinically expressed as chronic enterocolitis. A high effect of a single dose 10 mg/kg of azinox against metagonimiasis (98%) and nanophyetiasis (100%) was shown. The treatment course was proved to be useful in the foci of the Amur basin.
Authors	A M Bronshteĭn, V N Korablev, L S Iarotskiĭ
Journal	Meditsinskaia parazitologiia i parazitarnye bolezni (Med Parazitol (Mosk)) 1992 Mar-Apr Issue 2 Pg. 25-7 ISSN: 0025-8326 [Print] Russia (Federation)
Vernacular Title	Kishechnye trematodozy (metagonimoz, nanofietoz): kliniko-parazitologicheskoe issledovanie i pervyĭ opyt primeneniia azinoksa v ochage Nizhnego Priamur'ia.
PMID	1435530 (Publication Type: English Abstract, Journal Article)
Chemical References	azinox Praziquantel
Topics	Adolescent Adult Aged Animals Child Child, Preschool Disease Reservoirs Drug Evaluation Feces (parasitology) Female Heterophyidae Humans Intestinal Diseases, Parasitic (drug therapy, parasitology) Male Middle Aged Parasite Egg Count Praziquantel (analogs & derivatives, therapeutic use) Siberia Trematoda Trematode Infections (drug therapy, parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!